Luo and colleagues found that chronic ketamine administration suppressed the protein expression and phosphorylation of CaMKIIβ, ERK1/2, CREB, and NF-κB, leading to cognitive impairments [66]. Here, MAPK3 is linked to Cognitive impairment.